Innovative use of photodeoxygenation of sulfoxides and selenoxides to oxidize and lighten melanin under aerobic conditions. This method leverages atomic oxygen and ozone to achieve effective melanin modification, with potential applications in cosmetic and dermatological fields.
This research explores a novel photochemical approach to oxidize and lighten melanin using photodeoxygenation of heterocyclic sulfoxides and selenoxides. The process generates highly reactive atomic oxygen and ozone, which can effectively react with melanin, leading to its modification. This method has significant potential in cosmetic and dermatological applications for hair and skin lightening.
Key features:
The technology is at TRL 3, indicating that it is in the experimental proof-of-concept stage. Initial studies have demonstrated the potential of this approach, and further validation is planned to optimize reaction conditions and identify oxidation products.
Saint Louis University is a private Jesuit research university with comprehensive academic programs and an expanding research portfolio across urban and health‑sciences campuses in Midtown St. Louis. Industry engages through co‑located hospital and clinical environments that enable observational studies, trials, and access to diverse patient populations, supported by centralized core facilities and research computing. The university’s location in a dense innovation economy—near major corporate R&D, a mature startup district, and the region’s emerging geospatial corridor—facilitates sponsored research, internships, and joint development. Research activity is supported by competitive federal funding from agencies such as NIH, NSF, and DoD. A dedicated technology transfer office provides IP management, licensing, and startup support with streamlined contracting for industry partners.